MIRA INFORM REPORT

 

 

Report Date :

31.05.2011

 

IDENTIFICATION DETAILS

 

Name :

OCIMUM BIOSOLUTION  (INDIA) LIMITED

 

 

Registered Office :

6th Floor Reliance Classic, Road No.1, Banjarahills, Hyderabad-500034, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2009

 

 

Date of Incorporation :

12.03.2001

 

 

Com. Reg. No.:

01-036378       

 

 

Capital Investment / Paid-up Capital :

Rs. 218.919 Millions

 

                                

CIN No.:

[Company Identification No.]

U72100AP2001PLC036378

 

 

Legal Form:

A Closely held Public Limited Liability Company.

 

 

Line of Business :

The Company is engaged in the development of computer software, manufacturing of Microarrays chips and Oligonuclectides.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 33000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow  but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. There appear some accumulated losses being recorded by the company.  However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some cautions

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

(01.04.2010)

Current Rating

(30.06.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered/Corporate Office :

6th Floor Reliance Classic, Road No.1, Banjarahills, Hyderabad-500034, Andhra Pradesh, India

Tel. No.:

91-40-66986700

Fax No.:

91-40-66627205

E-Mail :

hyd@ocimumbio.com

nihita.s@ocimumbio.com

Website :

www.ocimumbio.com

 

 

DIRECTORS

As on 30.09.2010

 

Name :

Mrs. Anuradha Acharya

Designation :

Managing Director

Address :

Plot No.435/A, Road No. 20, Jubilee Hills, Hyderabad-500034, Andhra Pradesh, India

Date of Birth/Age :

27.06.1972

Date of Appointment :

12.03.2001

 

 

Name :

Mr. Subash Venkata Lingareddy

Designation :

Director,

Address :

Plot No.435/A, Road No. 20, Jubilee Hills, Hyderabad-500034, Andhra Pradesh, India

Date of Birth/Age :

09.12.1971

Date of Appointment :

12.03.2001

 

 

Name :

Mrs.Sujata Pammi

Designation :

Director

Address :

3704 Sumterway Carmel Indiana-46032, USA

Date of Birth/Age :

31.10.1958

Date of Appointment :

01.10.2005

 

 

Name :

Mr. Rammohan Rddy Venkata Bodanapu

Designation :

Director

Address :

1020 Road No. 46, Jubilee Hills, Hyderabad -500034, Andhra Pradesh

Date of Birth/Age :

12.10.1950

Date of Appointment :

01.10.2005

 

 

Name :

Mrs. Jayasuriya Kusum Anula

Designation :

Director

Address :

2610 Torelloln, losaltoshls, California -94022, USA

Date of Birth/Age :

19.12.1956

Date of Appointment :

16.03.2007

 

 

Name :

Mr. Ramanan Raghavendran

Designation :

Director

Address :

116w 29th Apt 6, New york-10001, USA

Date of Birth/Age :

14.1101968

Date of Appointment :

07.02.2008

 

 

Name :

Mr. Abhishek Maheshwari

Designation :

Director

Address :

B-25, Kalpataru Habitat, Dr. S.S. Rao Road, Parel, Mumbai-400012, Maharashtra, India.

Date of Birth/Age :

22.12.1974

Date of Appointment :

07.02.2008

 

 

Name :

Mr.David U. Prichard

Designation :

Director

Address :

121, Pine Street, Philedelphia-19106

Date of Birth/Age :

27.05.1948

Date of Appointment :

19.02.2010

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

As on 30.09.2010

 

Names of Shareholders

No. of Equity Shares

No. of Preference Shares

Anuradha Acharya

100

-

Sunitha Lingareddy

100

 

Subash Venkata Lingareddy

215,030

-

Sunil Venkata Lingareddy

876,600

-

Gargi Pammi

100

-

Mangama Avutu

               100

-

Kumar Phani

100

-

Anuradha Acharya and Subash V. Lingareddy

2,344,170

                          -

Subba Reddy Venkata LinGareddy

255,000

-

Kumar Nanda Bridavolu

8,000

-

Kumar Shravan Karpuram

10,000

-

Sujata Pammi

940,000

-

Winzer Ludwig

37,931

-

Ocimum Employees Welfare Trust

744,069

-

International Finance Corporation

500

13,135,215

Kubera Cross Border Fund Mauritius Limited

1,000

3,818,162

 

 

As on 20.12.2010

 

Names of Shareholders

No. of Equity Shares

No. of Preference Shares

L.V. Subash and Anuradha Acharya

2,413,670

                         -

Dr. L. Sunitha

215,030

-

Dr. L.V. Subba Reddy

255,000

-

L.V. Sunil

876,600

-

P.Gargi

100

-

A. Managamma

100

-

Dr. M.S. Phani Kumar

100

-

Dr. Sujata Pammi

940,000

-

Ludwig Winzer

37,931

-

Shravn

10,000

-

Nanda Kumar B

8,000

-

Trust (Ocimum Employee’s Welfare Trust)

744,069

-

Internation Finance Corporation

500

13,135,215

Kubera Cross Border Fund Mauritius Limited

1,000

3,818,162

Total

5,502,100

16,953,377

 

 

As on 30.09.2010

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings (Foreign institutional investor(s), Foreign companie(s) Foreign financial institut6ion(s), Non-resident Indian(s) or Overseas corporate bodies or Others)

 

00.72

Directors/ Relative of Directors

 

85.76

Other top 50 shareholders(Other than those listed above)

 

                            13.52                       

TOTAL

 

                         100.00

 

BUSINESS DETAILS

 

Line of Business :

The Company is engaged in the development of computer software, manufacturing of Microarrays chips and Oligonuclectides.

 

 

Products :

Item Code No.(ITC Code)

Product Description

38220090

Micro Arrays

29349900

Oligo/Spoligo

 

 

GENERAL INFORMATION

 

Bankers :

Axis Bank Limited -6-3-879/b, Green Lands Road, Begumpet, Hyderabad-500016, Andhra Pradesh, India.

 

 

Facilities :

Secured Loan

As on 31.03.2009

(Rs. In Million)

As on 31.03.2008

(Rs. In Million)

From Banks:

 

 

Term Loan

0.000

10.005

Working capital  loan

49.142

0.000

Interest accrued and due

0.000

0.107

From Others:

 

 

Term Loan

168.470

139.740

Vehicle Loan

2.165

0.000

Finance Lease obligation

6.357

3.631

TOTAL

226.134

153.483

 

Auditors :

 

Name :

SR Batliboi and Associates

Chartered Accountant

Address :

205, 2nd Floor, Ashoka Bhoopal Chambers,  Sardar Patel Road, Secunderabad -500003, Andhra Pradesh, India

                                PAN:

AABFS3421N

 

 

Associates/Subsidiaries :

Ocimum Biosolution Inc, USA

 

 

CAPITAL STRUCTURE

As on 30.09.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

12,000,000

Equity Share

Rs.10/- each

Rs.120.000 Million

20,000,000

Preference Share

RS.10/- each

Rs. 200.000 Million

 

 

 

 

32,000,000

TOTAL

 

Rs.320.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

5,502,100

Equity Share

Rs.10/- each

Rs.55.021 Million

16,953,377

Preference Share

Rs.10/- each

Rs.169.533 Million

 

 

 

 

22,455,477

TOTAL

 

Rs.224.554 Million

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2009

31.03.2008

31.03.2007

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

218.919

218.919

147.355

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

621.361

573.915

67.536

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

840.280

792.834

214.891

LOAN FUNDS

 

 

 

1] Secured Loans

                      226.134

153.483

151.443

2] Unsecured Loans

31.450

35.478

45.899

TOTAL BORROWING

257.584

188.961

197.342

DEFERRED TAX LIABILITIES

7.671

8.099

6.389

 

 

 

 

TOTAL

1105.535

989.894

418.622

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

203.388

188.227

164.015

Capital work-in-progress

44.286

1.284

0.000

 

 

 

 

INVESTMENT

461.540

94.855

94.855

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

24.658

23.140

22.485

 

Sundry Debtors

246.145

147.562

72.166

 

Cash & Bank Balances

4.117

87.590

6.860

 

Other Current Assets

15.055

0.000

0.000

 

Loans & Advances

160.131

460.444

93.874

Total Current Assets

450.106

718.736

195.385

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

48.338

15.799

40.258

 

Other Current Liabilities

6.856

7.557

5.643

 

Provisions

8.373

1.984

1.458

Total Current Liabilities

63.567

25.340

47.359

Net Current Assets

386.539

693.396

148.026

 

 

 

 

MISCELLANEOUS EXPENSES

9.782

12.132

11.726

 

 

 

 

TOTAL

1105.535

989.894

418.622

 

 

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2009

31.03.2008

31.03.2007

 

SALES

 

 

 

 

 

Income

196.119

162.853

87.181

 

 

Other Income

37.999

1.403

3.390

 

 

TOTAL                                     (A)

234.118

164.256

90.571

 

 

 

 

 

Less

EXPENSES

 

 

 

 

                        Material Consumed

16.403

4.340

2.058

 

                         Personal Expenses

66.073

54.395

33.265

 

 

Selling and Administrative Expenses

49.657

46.309

30.285

 

 

Royalty on sales

              0.448

0.816

1.156

 

 

Miscellaneous expenditure written off

2.350

2.349

1.955

 

 

Transferred from revaluation reserve

(2.420)

(2.420)

(4.840)

 

                        Prior period items

0.000

0.000

3.269

 

 

TOTAL                                     (B)

                 132.511

105.789

67.148

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

101.607

58.467

23.423

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

18.778

25.670

9.479

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

82.829

32.797

13.944

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

22.543

18.528

            14.618

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

60.286

14.269

(0.674)

 

 

 

 

 

Less

TAX                                                                  (I)

4.273

3.814

4.305

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

             56.013

10.455

(4.979)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

28.947

18.491

23.471

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

84.960

28.946

18.492

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

N.A.

142.210

76.777

 

TOTAL EARNINGS

N.A.

142.210

76.777

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Imports of consumables and fixed assets

N.A.

21.957

43.750

 

TOTAL IMPORTS

N.A.

21.957

43.750

 

 

 

 

 

 

Earnings Per Share (Rs.)

            11.77              

2.20

(1.18)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2009

31.03.2008

31.03.2007

PAT / Total Income

(%)

23.92

6.36

              (5.49)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

30.73

8.76

              (0.77)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.22

1.57

              (0.18)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.07

0.01

                 0.00

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.38

0.27

1.13

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

7.08

28.36

4.12

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Corporate identity number of the company

U72100AP2001PLC036378

Name of the company

OCIMUM BIO SOLUTIONS (INDIA) LIMITED

Address of the registered office or of the principal place of  business in India of the company

6th Floor Reliance Classic, Road No.1, Banjarahills, Hyderabad-500034, Andhra Pradesh, India

This form is for

Modification of charge

Type of charge

Immovable Property

Book Debts

Movable Property

Others: Excl. First Charge on FA Bought with above T. Loan.

Particular of charge holder

Name: AXIS BANK LIMITED

Address: 6-3-879/b, Green Lands Road, Begumpet, Hyderabad-500016, Andhra Pradesh, India.

E-Mail: BL.Sailaja@axisbank.com

Nature of instrument creating charge

Sanction Letter From The Bank

Memorandum of Entry

Supplemental Deed of Hypothecation Dated 06.04.2010

Date of instrument Creating the charge

06.04.2010

Amount secured by the charge

Rs.180.000 Million

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest: BPLR-3%PA.i.e. presently at 11.75%

 

Terms of Repayment: To be Repaid in 20 Quarterly installments of Rs.5.000 Million Each Starting From February 2011.

 

Margin: For CC: Inventory :25 %

Book Debts (Cover Period 120 days) 25%

For Term Loan: 55.85%

 

Extent and Operation of the Charge: First Charge in the Entire unencumbered Fixed Assets of the Company Both Present and Future Assets Ranking Paripassu With IFC

 

Exclusive First Charge on the Entire Fixed Assets of the Company Purchased From the Proposed Term Loan Excluding Land and Building (Which Would Be Charged Paripassu With IFC)

 

Extension of Fist Paripassu Charge on the Entire Current Assets, Present and Future of the Company.

 

Short Particulars of the Property or assets

As per Sanction Letter

Exclusive First Charge on the Fixed Assets Purchased Using the Term Loan From Axis Bank.

Charge identification number of the charge to be modified

 1001181

Particulars of the present modification

Limit Enhanced From Rs.80.000 Millions  to Rs.180.000 Million As Follows:

Cash Credit: Rs.50.000 Million

SBLC: Rs.30.000 Million

Term Loan New: Rs.100.000 Millions

 

Total Limit Stands At Rs.180.000 Millions

 

 

Review of Operations:

During the year, your company projected a satisfying performance. Out of the three division of the company namely, Bio IT, Bio Molecules and Bio Research, Bio IT divisions excelled in its performance and other lagged slightly due to the present global scenario and slump in the market. On the whole the performance was gratifying.

 

Bio IT:

 

The Bio IT division of the company especially the Info Products had demonstrated excellent performance making it the most profitable business this year. Apart from maintaining the current customers, company was successful acquiring new clientele also. The company also won the single largest license of $ 5.5 Million, which has added a new feather in the cap of the company. Your company has introduced a new Information products and services known as RAAS (Research as Service).

 

Bioresearch:

 

During the year, this division depicted a significant increase in the Master Service Agreements (MSA’s) that is grat move towards building strong customers relationships. This division has added new service lines like the Illumina and Biotrove platform. 

 

Bio Molecules:

 

This division depicted a sluggish growth due to slump in sale, which can partly be attributed to the global economic scenario.

 

Fixed Assets:-

 

§            Land and Building

§            Leasehold improvement

§            Computers

§            Furniture and Fixtures

§            Computer on finance lease

§            Plants and Machinery

§            Vehicles

§            Product software

§            Licenses


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.10

UK Pound

1

Rs.74.27

Euro

1

Rs.64.35

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

2

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.